Microvast Holdings, Inc. filings document the public reporting of an operating battery-technology company with Nasdaq-listed common stock and redeemable warrants. Recent Form 8-K reports cover operating results, financial presentations, material definitive agreements, executive officer changes, and stockholder-vote results for MVST.
Proxy materials describe annual-meeting matters such as director elections, auditor ratification, board structure, and shareholder voting mechanics. Capital-structure disclosures include common stock, warrants, and an at-the-market equity sales agreement, while earnings-related filings furnish consolidated results for Microvast's battery systems business.
Microvast Holdings, Inc. Chief Executive Officer Wu Yang reported an insider transaction involving the company’s common stock. On June 9, 2026, he sold 46,313 shares at $1.24 per share in a “sell to cover” trade to satisfy tax withholding tied to the settlement of restricted stock units under the Microvast Holdings, Inc. 2021 Equity Incentive Plan. After this disposition, he directly holds 134,065,439 shares of common stock and indirectly holds 1,000,000 shares through his son, who shares the reporting person’s household. The transaction is compensation- and tax-related rather than a discretionary open-market sale.
Microvast Holdings, Inc. director and CEO Wu Yang converted a $25,000,000 convertible loan into 50,000,000 shares of common stock at an effective conversion price of $0.50 per share. Following the conversion, he directly holds 134,111,752 shares of common stock and indirectly holds 1,000,000 shares through his son’s household. Yang also continues to hold a warrant exercisable for 5,500,000 shares of common stock at an exercise price of $2.00 per share, expiring on May 28, 2029. The filing reflects a significant shift from debt exposure to equity exposure rather than an open-market purchase or sale.
Microvast Holdings, Inc. reported two key developments. Chief Executive Officer Yang Wu elected to convert the full $25.0 million principal under his convertible loan agreement into shares of Microvast common stock, in line with the agreement’s terms and following the maturity extension to May 28, 2026.
The company also disclosed that, effective May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer. Microvast’s common stock and redeemable warrants continue to trade on The Nasdaq Stock Market under the symbols MVST and MVSTW.
Microvast Holdings, Inc. Chief Technology Officer Mattis Wenjuan reported an open-market sale of 48,346 shares of common stock at $1.32 per share. According to the footnote, these shares were sold solely to cover tax withholding obligations tied to the settlement of restricted and performance stock units under the company’s 2021 Equity Incentive Plan. After this transaction, Wenjuan directly holds 932,678 shares of Microvast common stock.
Microvast Holdings reported Q1 2026 financial results showing a sharp revenue decline and weaker profitability. Revenue was $60.6 million, down 48.0% from $116.5 million a year earlier, mainly due to regulatory and geopolitical pressures and delayed OEM ramps. Gross margin slipped to 31.6% from 36.9% as lower production utilization reduced fixed cost absorption.
GAAP net profit was $48.2 million, driven largely by a $63.8 million gain from changes in fair value of warrant liability and a convertible loan, but non-GAAP adjusted results showed a net loss of $14.6 million and adjusted EBITDA of negative $5.5 million versus positive $28.5 million in Q1 2025. Operating expenses declined modestly to $27.1 million. Cash, cash equivalents and restricted cash improved to $174.0 million as of March 31, 2026. Management highlights ramping the Huzhou Phase 3.2 expansion, targeting up to 2 GWh of new capacity, and launching 290Ah LFP packs and the KAF electric powertrain while aiming to maintain a “resilient” gross margin profile.
Microvast Holdings, Inc. director Ying Wei received an equity award of 20,000 restricted stock units of common stock as part of the company’s non-employee director compensation policy. This is a grant, not an open-market purchase or sale, and carries no cash exercise price.
Each restricted stock unit represents a contingent right to receive one share of Microvast common stock. The units vest on December 31, 2026, subject to Ying Wei’s continued service on the board through that date. Following this award, Ying Wei directly holds a total of 388,789 shares of Microvast common stock.
Pan Yixin reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings, Inc. director Pan Yixin received an equity award in the form of 20,000 shares of common stock on a grant basis. The award represents restricted stock units granted under the company’s non-employee director compensation policy at a price of $0.00 per share. Each restricted stock unit corresponds to one share of common stock and will vest on December 31, 2026, subject to continued board service through that date. Following this grant, Pan Yixin directly holds a total of 188,239 shares of Microvast common stock.
Wong Arthur Lap Tat reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings director Arthur Lap Tat Wong received an equity award rather than buying shares on the market. He was granted 20,000 restricted stock units under the non-employee director compensation policy, each equal to one common share. These units vest on December 31, 2026, assuming he continues to serve through that date. After this grant, he holds 237,473 common shares directly.
Microvast Holdings, Inc. Chief Operating Officer Wu Shengxian reported multiple equity-based compensation awards. The latest Form 4 shows grants of common stock and cash-settled restricted and performance stock units tied to the value of Microvast common shares.
The filing also reports a prior grant of an employee stock option covering 1,000,000 shares of common stock at an exercise price of $1.2900 per share, vesting in three equal installments starting on November 8, 2025 and expiring on December 5, 2034. Following the most recent grant on March 13, 2026, Wu directly holds 233,799 shares of common stock.